메뉴 건너뛰기




Volumn 2015, Issue , 2015, Pages

"adherent" versus Other Isolation Strategies for Expanding Purified, Potent, and Activated Human NK Cells for Cancer Immunotherapy

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; INTERLEUKIN 2;

EID: 84934312281     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/869547     Document Type: Review
Times cited : (12)

References (92)
  • 1
    • 81155124466 scopus 로고    scopus 로고
    • Natural killer cell engineering for cellular therapy of cancer
    • D. R. Shook and D. Campana, "Natural killer cell engineering for cellular therapy of cancer", Tissue Antigens, vol. 78, no. 6, pp. 409-415, 2011.
    • (2011) Tissue Antigens , vol.78 , Issue.6 , pp. 409-415
    • Shook, D.R.1    Campana, D.2
  • 2
    • 84883244752 scopus 로고    scopus 로고
    • Natural killer cell biology: An update and future directions
    • K. S. Campbell and J. Hasegawa, "Natural killer cell biology: an update and future directions", Journal of Allergy and Clinical Immunology, vol. 132, no. 3, pp. 536-544, 2013.
    • (2013) Journal of Allergy and Clinical Immunology , vol.132 , Issue.3 , pp. 536-544
    • Campbell, K.S.1    Hasegawa, J.2
  • 3
    • 73949138990 scopus 로고    scopus 로고
    • Natural killer cells and cancer: Regulation by the killer cell ig-like receptors (KIR)
    • A. K. Purdy and K. S. Campbell, "Natural killer cells and cancer: regulation by the killer cell ig-like receptors (KIR)", Cancer Biology and Therapy, vol. 8, no. 23, pp. 2211-2220, 2009.
    • (2009) Cancer Biology and Therapy , vol.8 , Issue.23 , pp. 2211-2220
    • Purdy, A.K.1    Campbell, K.S.2
  • 4
    • 79953151458 scopus 로고    scopus 로고
    • Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion
    • R. D. Schreiber, L. J. Old, and M. J. Smyth, "Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion", Science, vol. 331, no. 6024, pp. 1565-1570, 2011.
    • (2011) Science , vol.331 , Issue.6024 , pp. 1565-1570
    • Schreiber, R.D.1    Old, L.J.2    Smyth, M.J.3
  • 5
    • 0035874522 scopus 로고    scopus 로고
    • Human natural killer cells: A unique innate immunoregulatory role for the CD56bright subset
    • M. A. Cooper, T. A. Fehniger, S. C. Turner et al., "Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset", Blood, vol. 97, no. 10, pp. 3146-3151, 2001.
    • (2001) Blood , vol.97 , Issue.10 , pp. 3146-3151
    • Cooper, M.A.1    Fehniger, T.A.2    Turner, S.C.3
  • 6
    • 0035499063 scopus 로고    scopus 로고
    • The biology of human natural killer-cell subsets
    • M. A. Cooper, T. A. Fehniger, and M. A. Caligiuri, "The biology of human natural killer-cell subsets", Trends in Immunology, vol. 22, no. 11, pp. 633-640, 2001.
    • (2001) Trends in Immunology , vol.22 , Issue.11 , pp. 633-640
    • Cooper, M.A.1    Fehniger, T.A.2    Caligiuri, M.A.3
  • 7
    • 78149283616 scopus 로고    scopus 로고
    • Gene expression analysis of ex vivo expanded and freshly isolated NK cells from cancer patients
    • K. U. Park, P. Jin, M. Sabatino et al., "Gene expression analysis of ex vivo expanded and freshly isolated NK cells from cancer patients", Journal of Immunotherapy, vol. 33, no. 9, pp. 945-955, 2010.
    • (2010) Journal of Immunotherapy , vol.33 , Issue.9 , pp. 945-955
    • Park, K.U.1    Jin, P.2    Sabatino, M.3
  • 9
    • 84883808627 scopus 로고    scopus 로고
    • Evidence for natural killer cell memory
    • A. Marcus and D. H. Raulet, "Evidence for natural killer cell memory", Current Biology, vol. 23, no. 17, pp. R817-R820, 2013.
    • (2013) Current Biology , vol.23 , Issue.17 , pp. R817-R820
    • Marcus, A.1    Raulet, D.H.2
  • 10
    • 77956642196 scopus 로고    scopus 로고
    • Natural killer cell education and tolerance
    • M. T. Orr and L. L. Lanier, "Natural killer cell education and tolerance", Cell, vol. 142, no. 6, pp. 847-856, 2010.
    • (2010) Cell , vol.142 , Issue.6 , pp. 847-856
    • Orr, M.T.1    Lanier, L.L.2
  • 11
    • 79951695881 scopus 로고    scopus 로고
    • Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection
    • J. C. Sun, J. N. Beilke, N. A. Bezman, and L. L. Lanier, "Homeostatic proliferation generates long-lived natural killer cells that respond against viral infection", Journal of Experimental Medicine, vol. 208, no. 2, pp. 357-368, 2011.
    • (2011) Journal of Experimental Medicine , vol.208 , Issue.2 , pp. 357-368
    • Sun, J.C.1    Beilke, J.N.2    Bezman, N.A.3    Lanier, L.L.4
  • 12
    • 33645989497 scopus 로고    scopus 로고
    • T cell- and B cell-independent adaptive immunity mediated by natural killer cells
    • J. G. O'Leary, M. Goodarzi, D. L. Drayton, and U. H. Von Andrian, "T cell- and B cell-independent adaptive immunity mediated by natural killer cells", Nature Immunology, vol. 7, no. 5, pp. 507-516, 2006.
    • (2006) Nature Immunology , vol.7 , Issue.5 , pp. 507-516
    • O'Leary, J.G.1    Goodarzi, M.2    Drayton, D.L.3    Von Andrian, U.H.4
  • 13
    • 59049094662 scopus 로고    scopus 로고
    • Adaptive immune features of natural killer cells
    • J. C. Sun, J. N. Beilke, and L. L. Lanier, "Adaptive immune features of natural killer cells", Nature, vol. 457, pp. 557-561, 2009.
    • (2009) Nature , vol.457 , pp. 557-561
    • Sun, J.C.1    Beilke, J.N.2    Lanier, L.L.3
  • 15
    • 0024792513 scopus 로고
    • Biology of natural killer cells
    • G. Trinchieri, "Biology of natural killer cells", Advances in Immunology, vol. 47, pp. 187-376, 1989.
    • (1989) Advances in Immunology , vol.47 , pp. 187-376
    • Trinchieri, G.1
  • 17
    • 0035855872 scopus 로고    scopus 로고
    • Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity
    • A. Diefenbach, E. R. Jensen, A. M. Jamieson, and D. H. Raulet, "Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity", Nature, vol. 413, no. 6852, pp. 165-171, 2001.
    • (2001) Nature , vol.413 , Issue.6852 , pp. 165-171
    • Diefenbach, A.1    Jensen, E.R.2    Jamieson, A.M.3    Raulet, D.H.4
  • 18
    • 0035949563 scopus 로고    scopus 로고
    • Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo
    • A. Cerwenka, J. L. Baron, and L. L. Lanier, "Ectopic expression of retinoic acid early inducible-1 gene (RAE-1) permits natural killer cell-mediated rejection of a MHC class I-bearing tumor in vivo", Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 20, pp. 11521-11526, 2001.
    • (2001) Proceedings of the National Academy of Sciences of the United States of America , vol.98 , Issue.20 , pp. 11521-11526
    • Cerwenka, A.1    Baron, J.L.2    Lanier, L.L.3
  • 19
    • 0036143496 scopus 로고    scopus 로고
    • Induction of tumorspecific T cell memory by NK cell-mediated tumor rejection
    • J. M. Kelly, P. K. Darcy, J. L. Markby et al., "Induction of tumorspecific T cell memory by NK cell-mediated tumor rejection", Nature Immunology, vol. 3, no. 1, pp. 83-90, 2002.
    • (2002) Nature Immunology , vol.3 , Issue.1 , pp. 83-90
    • Kelly, J.M.1    Darcy, P.K.2    Markby, J.L.3
  • 20
    • 84868332376 scopus 로고    scopus 로고
    • Tumor induced inactivation of natural killer cell cytotoxic function; implication in growth, expansion and differentiation of cancer stem cells
    • A. Jewett and H.-C. Tseng, "Tumor induced inactivation of natural killer cell cytotoxic function; implication in growth, expansion and differentiation of cancer stem cells", Journal of Cancer, vol. 2, no. 1, pp. 443-457, 2011.
    • (2011) Journal of Cancer , vol.2 , Issue.1 , pp. 443-457
    • Jewett, A.1    Tseng, H.-C.2
  • 21
    • 79959350453 scopus 로고    scopus 로고
    • Natural killer cells in human cancer: From biological functions to clinical applications
    • J. Mordoh, E. M. Levy, and M. P. Roberti, "Natural killer cells in human cancer: from biological functions to clinical applications", Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 676198, 11 pages, 2011.
    • (2011) Journal of Biomedicine and Biotechnology , vol.2011 , pp. 11
    • Mordoh, J.1    Levy, E.M.2    Roberti, M.P.3
  • 22
    • 77957970532 scopus 로고    scopus 로고
    • Role of chemokines in the biology of natural killer cells
    • A. A. Maghazachi, "Role of chemokines in the biology of natural killer cells", Current Topics in Microbiology and Immunology, vol. 341, no. 1, pp. 37-58, 2010.
    • (2010) Current Topics in Microbiology and Immunology , vol.341 , Issue.1 , pp. 37-58
    • Maghazachi, A.A.1
  • 23
    • 84885458655 scopus 로고    scopus 로고
    • P53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells
    • A. Iannello, T. W. Thompson, M. Ardolino, S. W. Lowe, and D. H. Raulet, "p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells", Journal of Experimental Medicine, vol. 210, no. 10, pp. 2057-2069, 2013.
    • (2013) Journal of Experimental Medicine , vol.210 , Issue.10 , pp. 2057-2069
    • Iannello, A.1    Thompson, T.W.2    Ardolino, M.3    Lowe, S.W.4    Raulet, D.H.5
  • 24
    • 80054730378 scopus 로고    scopus 로고
    • Insights into NK cell biology from human genetics and disease associations
    • S. M. Wood, H.-G. Ljunggren, and Y. T. Bryceson, "Insights into NK cell biology from human genetics and disease associations", Cellular and Molecular Life Sciences, vol. 68, no. 21, pp. 3479-3493, 2011.
    • (2011) Cellular and Molecular Life Sciences , vol.68 , Issue.21 , pp. 3479-3493
    • Wood, S.M.1    Ljunggren, H.-G.2    Bryceson, Y.T.3
  • 25
    • 48149097734 scopus 로고    scopus 로고
    • NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy
    • K. Malmberg, Y. Bryceson, M. Carlsten et al., "NK cell-mediated targeting of human cancer and possibilities for new means of immunotherapy", Cancer Immunology, Immunotherapy, vol. 57, no. 10, 2008.
    • (2008) Cancer Immunology, Immunotherapy , vol.57 , Issue.10
    • Malmberg, K.1    Bryceson, Y.2    Carlsten, M.3
  • 26
    • 84883208183 scopus 로고    scopus 로고
    • Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies
    • Article ID Article 76
    • U. J. E. Seidel, P. Schlegel, and P. Lang, "Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies", Frontiers in Immunology, vol. 4, article 76, Article ID Article 76, 2013.
    • (2013) Frontiers in Immunology , vol.4
    • Seidel, U.J.E.1    Schlegel, P.2    Lang, P.3
  • 28
    • 84903215048 scopus 로고    scopus 로고
    • CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets
    • M. K. Gleason, J. A. Ross, E. D. Warlick et al., "CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets", Blood, vol. 123, pp. 3016-3026, 2014.
    • (2014) Blood , vol.123 , pp. 3016-3026
    • Gleason, M.K.1    Ross, J.A.2    Warlick, E.D.3
  • 29
    • 65949111530 scopus 로고    scopus 로고
    • Expansion of highly cytotoxic human natural killer cells for cancer cell therapy
    • H. Fujisaki, H. Kakuda, N. Shimasaki et al., "Expansion of highly cytotoxic human natural killer cells for cancer cell therapy", Cancer Research, vol. 69, no. 9, pp. 4010-4017, 2009.
    • (2009) Cancer Research , vol.69 , Issue.9 , pp. 4010-4017
    • Fujisaki, H.1    Kakuda, H.2    Shimasaki, N.3
  • 30
    • 42449160619 scopus 로고    scopus 로고
    • Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components
    • E. Alici, T. Sutlu, B. Björkstrand et al., "Autologous antitumor activity by NK cells expanded from myeloma patients using GMP-compliant components", Blood, vol. 111, no. 6, pp. 3155-3162, 2008.
    • (2008) Blood , vol.111 , Issue.6 , pp. 3155-3162
    • Alici, E.1    Sutlu, T.2    Björkstrand, B.3
  • 31
    • 68049132603 scopus 로고    scopus 로고
    • Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells
    • M. Berg, A. Lundqvist, P. McCoy Jr. et al., "Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells", Cytotherapy, vol. 11, no. 3, pp. 341-355, 2009.
    • (2009) Cytotherapy , vol.11 , Issue.3 , pp. 341-355
    • Berg, M.1    Lundqvist, A.2    McCoy, P.3
  • 32
    • 1542315428 scopus 로고    scopus 로고
    • Ex vivo expansion of natural killer cells for clinical applications
    • H.-G. Klingemann and J. Martinson, "Ex vivo expansion of natural killer cells for clinical applications", Cytotherapy, vol. 6, no. 1, pp. 15-22, 2004.
    • (2004) Cytotherapy , vol.6 , Issue.1 , pp. 15-22
    • Klingemann, H.-G.1    Martinson, J.2
  • 33
    • 78649732786 scopus 로고    scopus 로고
    • Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokineinduced killer (CIK) cells in clinical-grade cultures
    • G. Bonanno, P. Iudicone, A. Mariotti et al., "Thymoglobulin, interferon-γ and interleukin-2 efficiently expand cytokineinduced killer (CIK) cells in clinical-grade cultures", Journal of Translational Medicine, vol. 8, article 129, 2010.
    • (2010) Journal of Translational Medicine , vol.8
    • Bonanno, G.1    Iudicone, P.2    Mariotti, A.3
  • 35
    • 0036233414 scopus 로고    scopus 로고
    • Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT
    • H. Harada, K. Saijo, S. Watanabe et al., "Selective expansion of human natural killer cells from peripheral blood mononuclear cells by the cell line, HFWT", Japanese Journal of Cancer Research, vol. 93, no. 3, pp. 313-319, 2002.
    • (2002) Japanese Journal of Cancer Research , vol.93 , Issue.3 , pp. 313-319
    • Harada, H.1    Saijo, K.2    Watanabe, S.3
  • 36
    • 84875480259 scopus 로고    scopus 로고
    • Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers
    • E.-K. Kim, Y.-O. Ahn, S. Kim, T. M. Kim, B. Keam, and D. S. Heo, "Ex vivo activation and expansion of natural killer cells from patients with advanced cancer with feeder cells from healthy volunteers", Cytotherapy, vol. 15, no. 2, pp. 231-241, 2013.
    • (2013) Cytotherapy , vol.15 , Issue.2 , pp. 231-241
    • Kim, E.-K.1    Ahn, Y.-O.2    Kim, S.3    Kim, T.M.4    Keam, B.5    Heo, D.S.6
  • 37
    • 77955119958 scopus 로고    scopus 로고
    • Cytotoxicity of activated natural killer cells against pediatric solid tumors
    • D. Cho, D. R. Shook, N. Shimasaki, Y.-H. Chang, H. Fujisaki, and D. Campana, "Cytotoxicity of activated natural killer cells against pediatric solid tumors", Clinical Cancer Research, vol. 16, no. 15, pp. 3901-3909, 2010.
    • (2010) Clinical Cancer Research , vol.16 , Issue.15 , pp. 3901-3909
    • Cho, D.1    Shook, D.R.2    Shimasaki, N.3    Chang, Y.-H.4    Fujisaki, H.5    Campana, D.6
  • 38
    • 0346119082 scopus 로고    scopus 로고
    • Induction of potent antitumour natural-killer cells from peripheral blood of patients with advanced prostate cancer
    • T. Oikawa, K. Kawai, I. Ishiwata, T. Ohno, and H. Akaza, "Induction of potent antitumour natural-killer cells from peripheral blood of patients with advanced prostate cancer", BJU International, vol. 92, no. 9, pp. 1009-1015, 2003.
    • (2003) BJU International , vol.92 , Issue.9 , pp. 1009-1015
    • Oikawa, T.1    Kawai, K.2    Ishiwata, I.3    Ohno, T.4    Akaza, H.5
  • 39
    • 20144388509 scopus 로고    scopus 로고
    • Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer
    • J. S. Miller, Y. Soignier, A. Panoskaltsis-Mortari et al., "Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer", Blood, vol. 105, no. 8, pp. 3051-3057, 2005.
    • (2005) Blood , vol.105 , Issue.8 , pp. 3051-3057
    • Miller, J.S.1    Soignier, Y.2    Panoskaltsis-Mortari, A.3
  • 40
    • 77949898005 scopus 로고    scopus 로고
    • NKAML: A pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia
    • J. E. Rubnitz, H. Inaba, R. C. Ribeiro et al., "NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia", Journal of Clinical Oncology, vol. 28, no. 6, pp. 955-959, 2010.
    • (2010) Journal of Clinical Oncology , vol.28 , Issue.6 , pp. 955-959
    • Rubnitz, J.E.1    Inaba, H.2    Ribeiro, R.C.3
  • 41
    • 80053208226 scopus 로고    scopus 로고
    • Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
    • A. Curti, L. Ruggeri, A. D'Addio et al., "Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients", Blood, vol. 118, no. 12, pp. 3273-3279, 2011.
    • (2011) Blood , vol.118 , Issue.12 , pp. 3273-3279
    • Curti, A.1    Ruggeri, L.2    D'Addio, A.3
  • 42
    • 84875230309 scopus 로고    scopus 로고
    • Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: A prospective phase II study in two centers
    • M. Stern, J. R. Passweg, S. Meyer-Monard et al., "Pre-emptive immunotherapy with purified natural killer cells after haploidentical SCT: a prospective phase II study in two centers", Bone Marrow Transplantation, vol. 48, no. 3, pp. 433-438, 2013.
    • (2013) Bone Marrow Transplantation , vol.48 , Issue.3 , pp. 433-438
    • Stern, M.1    Passweg, J.R.2    Meyer-Monard, S.3
  • 43
    • 0023630792 scopus 로고
    • Lymphokine activated killer (LAK) cells in patients with gastrointestinal cancer
    • J. R. T. Monson, C. W. Ramsden, G. R. Giles, T. G. Brennan, and P. J. Guillou, "Lymphokine activated killer (LAK) cells in patients with gastrointestinal cancer", Gut, vol. 28, no. 11, pp. 1420-1425, 1987.
    • (1987) Gut , vol.28 , Issue.11 , pp. 1420-1425
    • Monson, J.R.T.1    Ramsden, C.W.2    Giles, G.R.3    Brennan, T.G.4    Guillou, P.J.5
  • 44
    • 0027860412 scopus 로고
    • Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells
    • I. G. H. Schmidt-Wolf, P. Lefterova, B. A. Mehta et al., "Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells", Experimental Hematology, vol. 21, no. 13, pp. 1673-1679, 1993.
    • (1993) Experimental Hematology , vol.21 , Issue.13 , pp. 1673-1679
    • Schmidt-Wolf, I.G.H.1    Lefterova, P.2    Mehta, B.A.3
  • 45
    • 0019448114 scopus 로고
    • Interleukin-2 augments natural killer cell activity
    • C. S. Henney, K. Kuribayashi, D. E. Kern, and S. Gillis, "Interleukin-2 augments natural killer cell activity", Nature, vol. 291, no. 5813, pp. 335-338, 1981.
    • (1981) Nature , vol.291 , Issue.5813 , pp. 335-338
    • Henney, C.S.1    Kuribayashi, K.2    Kern, D.E.3    Gillis, S.4
  • 46
    • 0021796903 scopus 로고
    • Recombinant interleukin 2 rapidly augments human natural killer cell activity
    • D. Kabelitz, H. Kirchner, D. Armerding, and H. Wagner, "Recombinant interleukin 2 rapidly augments human natural killer cell activity", Cellular Immunology, vol. 93, no. 1, pp. 38-45, 1985.
    • (1985) Cellular Immunology , vol.93 , Issue.1 , pp. 38-45
    • Kabelitz, D.1    Kirchner, H.2    Armerding, D.3    Wagner, H.4
  • 47
    • 0023104794 scopus 로고
    • Induction of NK cell activity against fresh human leukemia in culture with interleukin 2
    • E. Lotzová, C. A. Savary, and R. B. Herberman, "Induction of NK cell activity against fresh human leukemia in culture with interleukin 2", Journal of Immunology, vol. 138, no. 8, pp. 2718-2727, 1987.
    • (1987) Journal of Immunology , vol.138 , Issue.8 , pp. 2718-2727
    • Lotzová, E.1    Savary, C.A.2    Herberman, R.B.3
  • 48
    • 84880669245 scopus 로고    scopus 로고
    • IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells
    • G. Gasteiger, S. Hemmers, M. A. Firth et al., "IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells", The Journal of Experimental Medicine, vol. 210, no. 6, pp. 1167-1178, 2013.
    • (2013) The Journal of Experimental Medicine , vol.210 , Issue.6 , pp. 1167-1178
    • Gasteiger, G.1    Hemmers, S.2    Firth, M.A.3
  • 49
    • 79551643122 scopus 로고    scopus 로고
    • Emerging natural killer cell immunotherapies: Large-scale ex vivo production of highly potent anticancer effectors
    • G. Suck and M. B. C. Koh, "Emerging natural killer cell immunotherapies: large-scale ex vivo production of highly potent anticancer effectors", Hematology/Oncology and Stem Cell Therapy, vol. 3, no. 3, pp. 135-142, 2010.
    • (2010) Hematology/Oncology and Stem Cell Therapy , vol.3 , Issue.3 , pp. 135-142
    • Suck, G.1    Koh, M.B.C.2
  • 50
    • 0028812791 scopus 로고
    • Mechanisms of action and overview of OKT3
    • D. J. Norman, "Mechanisms of action and overview of OKT3", Therapeutic Drug Monitoring, vol. 17, no. 6, pp. 615-620, 1995.
    • (1995) Therapeutic Drug Monitoring , vol.17 , Issue.6 , pp. 615-620
    • Norman, D.J.1
  • 51
    • 77953404092 scopus 로고    scopus 로고
    • Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: A phase I clinical study
    • L. Barkholt, E. Alici, R. Conrad et al., "Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study", Immunotherapy, vol. 1, no. 5, pp. 753-764, 2009.
    • (2009) Immunotherapy , vol.1 , Issue.5 , pp. 753-764
    • Barkholt, L.1    Alici, E.2    Conrad, R.3
  • 52
    • 78649303217 scopus 로고    scopus 로고
    • Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor
    • T. Sutlu, B. Stellan, M. Gilljam et al., "Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor", Cytotherapy, vol. 12, no. 8, pp. 1044-1055, 2010.
    • (2010) Cytotherapy , vol.12 , Issue.8 , pp. 1044-1055
    • Sutlu, T.1    Stellan, B.2    Gilljam, M.3
  • 53
    • 77951499495 scopus 로고    scopus 로고
    • Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: Comparison of three cytokines, IL-2, IL-15, or IL-7 and impacton NKG2D, KIR2DL1, and KIR2DL2 expression
    • V. Decot, L. Voillard, V. Latger-Cannard et al., "Natural-killer cell amplification for adoptive leukemia relapse immunotherapy: comparison of three cytokines, IL-2, IL-15, or IL-7 and impactonNKG2D, KIR2DL1, and KIR2DL2 expression, "Experimental Hematology, vol. 38, no. 5, pp. 351-362, 2010.
    • (2010) Experimental Hematology , vol.38 , Issue.5 , pp. 351-362
    • Decot, V.1    Voillard, L.2    Latger-Cannard, V.3
  • 54
    • 2942755603 scopus 로고    scopus 로고
    • Characterization of interleukin-15 gene-modified human natural killer cells: Implications for adoptive cellular immunotherapy
    • J. Zhang, R. Sun, H. Wei, and Z. Tian, "Characterization of interleukin-15 gene-modified human natural killer cells: implications for adoptive cellular immunotherapy", Haematologica, vol. 89, no. 3, pp. 338-347, 2004.
    • (2004) Haematologica , vol.89 , Issue.3 , pp. 338-347
    • Zhang, J.1    Sun, R.2    Wei, H.3    Tian, Z.4
  • 56
    • 84888373627 scopus 로고    scopus 로고
    • Homeostasis of human NK cells is not IL-15 dependent
    • H. Lebrec, M. J. Horner, K. S. Gorski et al., "Homeostasis of human NK cells is not IL-15 dependent", The Journal of Immunology, vol. 191, no. 11, pp. 5551-5558, 2013.
    • (2013) The Journal of Immunology , vol.191 , Issue.11 , pp. 5551-5558
    • Lebrec, H.1    Horner, M.J.2    Gorski, K.S.3
  • 57
    • 79961214176 scopus 로고    scopus 로고
    • Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies
    • G. Suck, V. Y. S. Oei, Y. C. Linn et al., "Interleukin-15 supports generation of highly potent clinical-grade natural killer cells in long-term cultures for targeting hematological malignancies", Experimental Hematology, vol. 39, no. 9, pp. 904-914, 2011.
    • (2011) Experimental Hematology , vol.39 , Issue.9 , pp. 904-914
    • Suck, G.1    Oei, V.Y.S.2    Linn, Y.C.3
  • 58
    • 84863365408 scopus 로고    scopus 로고
    • Interleukin-21 increases direct cytotoxicity and IFN-γ production of Ex Vivo expanded nk cells towards breast cancer cells
    • Y.-K. Park, D.-J. Shin, D. Cho et al., "Interleukin-21 increases direct cytotoxicity and IFN-γ production of Ex Vivo expanded nk cells towards breast cancer cells", Anticancer Research, vol. 32, no. 3, pp. 839-846, 2012.
    • (2012) Anticancer Research , vol.32 , Issue.3 , pp. 839-846
    • Park, Y.-K.1    Shin, D.-J.2    Cho, D.3
  • 59
    • 0025858813 scopus 로고
    • Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells
    • H. Rabinowich, P. Sedlmayr, R. B. Herberman, and T. L. Whiteside, "Increased proliferation, lytic activity, and purity of human natural killer cells cocultured with mitogen-activated feeder cells", Cellular Immunology, vol. 135, no. 2, pp. 454-470, 1991.
    • (1991) Cellular Immunology , vol.135 , Issue.2 , pp. 454-470
    • Rabinowich, H.1    Sedlmayr, P.2    Herberman, R.B.3    Whiteside, T.L.4
  • 60
    • 80054102468 scopus 로고    scopus 로고
    • NK cells: Immune cross-talk and therapeutic implications
    • A. Malhotra and A. Shanker, "NK cells: immune cross-talk and therapeutic implications", Immunotherapy, vol. 3, no. 10, pp. 1143-1166, 2011.
    • (2011) Immunotherapy , vol.3 , Issue.10 , pp. 1143-1166
    • Malhotra, A.1    Shanker, A.2
  • 61
    • 3242720680 scopus 로고    scopus 로고
    • Autologous natural killer cell therapy for human recurrent malignant glioma
    • E. Ishikawa, K. Tsuboi, K. Saijo et al., "Autologous natural killer cell therapy for human recurrent malignant glioma", Anticancer Research, vol. 24, no. 3 B, pp. 1861-1871, 2004.
    • (2004) Anticancer Research , vol.24 , Issue.3 B , pp. 1861-1871
    • Ishikawa, E.1    Tsuboi, K.2    Saijo, K.3
  • 63
    • 22044456688 scopus 로고    scopus 로고
    • Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells
    • C. Imai, S. Iwamoto, and D. Campana, "Genetic modification of primary natural killer cells overcomes inhibitory signals and induces specific killing of leukemic cells", Blood, vol. 106, no. 1, pp. 376-383, 2005.
    • (2005) Blood , vol.106 , Issue.1 , pp. 376-383
    • Imai, C.1    Iwamoto, S.2    Campana, D.3
  • 64
    • 11244255868 scopus 로고    scopus 로고
    • Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance
    • H. Kobayashi, S. Dubois, N. Sato et al., "Role of trans-cellular IL-15 presentation in the activation of NK cell-mediated killing, which leads to enhanced tumor immunosurveillance", Blood, vol. 105, no. 2, pp. 721-727, 2005.
    • (2005) Blood , vol.105 , Issue.2 , pp. 721-727
    • Kobayashi, H.1    Dubois, S.2    Sato, N.3
  • 65
    • 84863915982 scopus 로고    scopus 로고
    • A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignancies
    • N. Shimasaki, H. Fujisaki, D. Cho et al., "A clinically adaptable method to enhance the cytotoxicity of natural killer cells against B-cell malignancies", Cytotherapy, vol. 14, no. 7, pp. 830-840, 2012.
    • (2012) Cytotherapy , vol.14 , Issue.7 , pp. 830-840
    • Shimasaki, N.1    Fujisaki, H.2    Cho, D.3
  • 66
    • 84862908673 scopus 로고    scopus 로고
    • Membranebound IL-21 promotes sustained ex vivo proliferation of human natural killer cells
    • C. J. Denman, V. V. Senyukov, S. S. Somanchi et al., "Membranebound IL-21 promotes sustained ex vivo proliferation of human natural killer cells", PLoS ONE, vol. 7, no. 1, Article ID e30264, 2012.
    • (2012) PLoS ONE , vol.7 , Issue.1
    • Denman, C.J.1    Senyukov, V.V.2    Somanchi, S.S.3
  • 67
    • 84877089624 scopus 로고    scopus 로고
    • Growth and activation of natural killer cells Ex Vivo from children with neuroblastoma for adoptive cell therapy
    • Y. Liu, H.-W. Wu, M. A. Sheard et al., "Growth and activation of natural killer cells Ex Vivo from children with neuroblastoma for adoptive cell therapy", Clinical Cancer Research, vol. 19, no. 8, pp. 2132-2143, 2013.
    • (2013) Clinical Cancer Research , vol.19 , Issue.8 , pp. 2132-2143
    • Liu, Y.1    Wu, H.-W.2    Sheard, M.A.3
  • 68
    • 84862487272 scopus 로고    scopus 로고
    • Long-term proliferation of functional human NK cells, with conversion of CD56 dim NK cells to a CD56 bright phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12
    • A. C. Dowell, K. A. Oldham, R. I. Bhatt, S. P. Lee, and P. F. Searle, "Long-term proliferation of functional human NK cells, with conversion of CD56 dim NK cells to a CD56 bright phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12", Cancer Immunology, Immunotherapy, vol. 61, no. 5, pp. 615-628, 2012.
    • (2012) Cancer Immunology, Immunotherapy , vol.61 , Issue.5 , pp. 615-628
    • Dowell, A.C.1    Oldham, K.A.2    Bhatt, R.I.3    Lee, S.P.4    Searle, P.F.5
  • 69
    • 84861669615 scopus 로고    scopus 로고
    • Bortezomib treatment to potentiate the anti-tumor immunity of ex-vivo expanded adoptively infused autologous natural killer cells
    • A. Lundqvist, M. Berg, A. Smith, and R. W. Childs, "Bortezomib treatment to potentiate the anti-tumor immunity of ex-vivo expanded adoptively infused autologous natural killer cells", Journal of Cancer, vol. 2, no. 1, pp. 383-385, 2011.
    • (2011) Journal of Cancer , vol.2 , Issue.1 , pp. 383-385
    • Lundqvist, A.1    Berg, M.2    Smith, A.3    Childs, R.W.4
  • 71
    • 77957300466 scopus 로고    scopus 로고
    • Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients
    • U. Siegler, S. Meyer-Monard, S. Jrger et al., "Good manufacturing practice-compliant cell sorting and large-scale expansion of single KIR-positive alloreactive human natural killer cells for multiple infusions to leukemia patients", Cytotherapy, vol. 12, no. 6, pp. 750-763, 2010.
    • (2010) Cytotherapy , vol.12 , Issue.6 , pp. 750-763
    • Siegler, U.1    Meyer-Monard, S.2    Jrger, S.3
  • 72
    • 77957653695 scopus 로고    scopus 로고
    • Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity
    • C. J. Voskens, R. Watanabe, S. Rollins, D. Campana, K. Hasumi, and D. L. Mann, "Ex-vivo expanded human NK cells express activating receptors that mediate cytotoxicity of allogeneic and autologous cancer cell lines by direct recognition and antibody directed cellular cytotoxicity", Journal of Experimental and Clinical Cancer Research, vol. 29, no. 1, article 134, 2010.
    • (2010) Journal of Experimental and Clinical Cancer Research , vol.29 , Issue.1
    • Voskens, C.J.1    Watanabe, R.2    Rollins, S.3    Campana, D.4    Hasumi, K.5    Mann, D.L.6
  • 73
    • 84872253849 scopus 로고    scopus 로고
    • GMP-compliant, large-scale expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells in Vitro and in Vivo
    • O. Lim, Y. Lee, H. Chung et al., "GMP-compliant, large-scale expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells In Vitro and In Vivo", PLoS ONE, vol. 8, no. 1, Article ID e53611, 2013.
    • (2013) PLoS ONE , vol.8 , Issue.1
    • Lim, O.1    Lee, Y.2    Chung, H.3
  • 74
    • 80053465574 scopus 로고    scopus 로고
    • Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression
    • M. R. Parkhurst, J. P. Riley, M. E. Dudley, and S. A. Rosenberg, "Adoptive transfer of autologous natural killer cells leads to high levels of circulating natural killer cells but does not mediate tumor regression", Clinical Cancer Research, vol. 17, no. 19, pp. 6287-6297, 2011.
    • (2011) Clinical Cancer Research , vol.17 , Issue.19 , pp. 6287-6297
    • Parkhurst, M.R.1    Riley, J.P.2    Dudley, M.E.3    Rosenberg, S.A.4
  • 75
    • 0025307375 scopus 로고
    • Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells
    • R. J. Melder, E. R. Walker, R. B. Herberman, and T. L. Whiteside, "Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells", Journal of Leukocyte Biology, vol. 48, no. 2, pp. 163-173, 1990.
    • (1990) Journal of Leukocyte Biology , vol.48 , Issue.2 , pp. 163-173
    • Melder, R.J.1    Walker, E.R.2    Herberman, R.B.3    Whiteside, T.L.4
  • 76
    • 0026013022 scopus 로고
    • Adhesion characteristics of human interleukin 2-activated natural killer cells
    • R. J. Melder, E. Walker, R. B. Herberman, and T. L. Whiteside, "Adhesion characteristics of human interleukin 2-activated natural killer cells", Cellular Immunology, vol. 132, no. 1, pp. 177-192, 1991.
    • (1991) Cellular Immunology , vol.132 , Issue.1 , pp. 177-192
    • Melder, R.J.1    Walker, E.2    Herberman, R.B.3    Whiteside, T.L.4
  • 77
    • 0027381473 scopus 로고
    • Distinct phenotypic and functional chracteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic
    • N. L. Vujanovic, H. Rabinowich, Y. J. Lee, L. Jost, R. B. Herberman, and T. L. Whiteside, "Distinct phenotypic and functional chracteristics of human natural killer cells obtained by rapid interleukin 2-induced adherence to plastic", Cellular Immunology, vol. 151, no. 1, pp. 133-157, 1993.
    • (1993) Cellular Immunology , vol.151 , Issue.1 , pp. 133-157
    • Vujanovic, N.L.1    Rabinowich, H.2    Lee, Y.J.3    Jost, L.4    Herberman, R.B.5    Whiteside, T.L.6
  • 78
    • 0025819541 scopus 로고
    • In vitro and in vivo comparison of the activity of human lymphokine-activated killer (LAK) cells and adherent LAK cells
    • C. Jemma, A. Cignetti, M. Geuna, P. Caretto, S. Vai, and G. Forni, "In vitro and in vivo comparison of the activity of human lymphokine-activated killer (LAK) cells and adherent LAK cells", Journal of Immunotherapy, vol. 10, no. 3, pp. 189-199, 1991.
    • (1991) Journal of Immunotherapy , vol.10 , Issue.3 , pp. 189-199
    • Jemma, C.1    Cignetti, A.2    Geuna, M.3    Caretto, P.4    Vai, S.5    Forni, G.6
  • 79
    • 0028815217 scopus 로고
    • Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues
    • N. L. Vujanovic, S. Yasumura, H. Hirabayashi et al., "Antitumor activities of subsets of human IL-2-activated natural killer cells in solid tissues", The Journal of Immunology, vol. 154, no. 1, pp. 281-289, 1995.
    • (1995) The Journal of Immunology , vol.154 , Issue.1 , pp. 281-289
    • Vujanovic, N.L.1    Yasumura, S.2    Hirabayashi, H.3
  • 80
    • 0031896593 scopus 로고    scopus 로고
    • Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: Comparisons of antitumor effects in vitro and in vivo
    • T. L. Whiteside, M.-W. Sung, S. Nagashima, K. Chikamatsu, K. Okada, and N. L. Vujanovic, "Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo", Clinical Cancer Research, vol. 4, no. 5, pp. 1135-1145, 1998.
    • (1998) Clinical Cancer Research , vol.4 , Issue.5 , pp. 1135-1145
    • Whiteside, T.L.1    Sung, M.-W.2    Nagashima, S.3    Chikamatsu, K.4    Okada, K.5    Vujanovic, N.L.6
  • 82
    • 0027158409 scopus 로고
    • Costimulatory signals are required for optimal proliferation of human natural killer cells
    • M. J. Robertson, T. J. Manley, C. Donahue, H. Levine, and J. Ritz, "Costimulatory signals are required for optimal proliferation of human natural killer cells", Journal of Immunology, vol. 150, no. 5, pp. 1705-1714, 1993.
    • (1993) Journal of Immunology , vol.150 , Issue.5 , pp. 1705-1714
    • Robertson, M.J.1    Manley, T.J.2    Donahue, C.3    Levine, H.4    Ritz, J.5
  • 83
    • 9844221953 scopus 로고    scopus 로고
    • Costimulation of human natural killer cell proliferation: Role of accessory cytokines and cell contactdependent signals
    • M. J. Robertson, C. Cameron, S. Lazo, K. J. Cochran, S. D. Voss, and J. Ritz, "Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contactdependent signals", Natural Immunity, vol. 15, no. 5, pp. 213-226, 1997.
    • (1997) Natural Immunity , vol.15 , Issue.5 , pp. 213-226
    • Robertson, M.J.1    Cameron, C.2    Lazo, S.3    Cochran, K.J.4    Voss, S.D.5    Ritz, J.6
  • 84
    • 0025877252 scopus 로고
    • Proliferation and activation of human mononuclear cells induced by ionomycin in a serumfree medium
    • H. Jouishomme and D. Rigal, "Proliferation and activation of human mononuclear cells induced by ionomycin in a serumfree medium", Thymus, vol. 17, no. 3, pp. 137-146, 1991.
    • (1991) Thymus , vol.17 , Issue.3 , pp. 137-146
    • Jouishomme, H.1    Rigal, D.2
  • 86
    • 84879703012 scopus 로고    scopus 로고
    • NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17 (ADAM17)
    • R. Romee, B. Foley, T. Lenvik et al., "NK cell CD16 surface expression and function is regulated by a disintegrin and metalloprotease-17(ADAM17)", Blood, vol. 121, no. 18, pp. 3599-3608, 2013.
    • (2013) Blood , vol.121 , Issue.18 , pp. 3599-3608
    • Romee, R.1    Foley, B.2    Lenvik, T.3
  • 87
    • 84878784248 scopus 로고    scopus 로고
    • Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based antitumour immunotherapy
    • Q. Zhou, A. Gil-Krzewska, G. Peruzzi, and F. Borrego, "Matrix metalloproteinases inhibition promotes the polyfunctionality of human natural killer cells in therapeutic antibody-based antitumour immunotherapy", Clinical and Experimental Immunology, vol. 173, no. 1, pp. 131-139, 2013.
    • (2013) Clinical and Experimental Immunology , vol.173 , Issue.1 , pp. 131-139
    • Zhou, Q.1    Gil-Krzewska, A.2    Peruzzi, G.3    Borrego, F.4
  • 88
    • 0031803278 scopus 로고    scopus 로고
    • Differential expression and function of L-selectin on CD56 (bright) and CD56 (dim) natural killer cell subsets
    • M. Frey, N. B. Packianathan, T. A. Fehniger et al., "Differential expression and function of L-selectin on CD56 (bright) and CD56 (dim) natural killer cell subsets", The Journal of Immunology, vol. 161, no. 1, pp. 400-408, 1998.
    • (1998) The Journal of Immunology , vol.161 , Issue.1 , pp. 400-408
    • Frey, M.1    Packianathan, N.B.2    Fehniger, T.A.3
  • 89
    • 77956503431 scopus 로고    scopus 로고
    • CD62L expression identifies a unique subset of polyfunctional CD56 dim NK cells
    • K. Juelke, M. Killig, M. Luetke-Eversloh et al., "CD62L expression identifies a unique subset of polyfunctional CD56 dim NK cells", Blood, vol. 116, no. 8, pp. 1299-1307, 2010.
    • (2010) Blood , vol.116 , Issue.8 , pp. 1299-1307
    • Juelke, K.1    Killig, M.2    Luetke-Eversloh, M.3
  • 90
    • 84930467910 scopus 로고    scopus 로고
    • Nicotinamide, a form of vitamin B3, promotes expansion of natural killer cells that display increased in vivo survival and cytotoxic activity
    • G. M. Frei, N. Persi, C. Lador et al., "Nicotinamide, a form of vitamin B3, promotes expansion of natural killer cells that display increased in vivo survival and cytotoxic activity", Blood (ASH Annual Meeting Abstracts), vol. 118, p. 4035, 2011.
    • (2011) Blood (ASH Annual Meeting Abstracts) , vol.118 , pp. 4035
    • Frei, G.M.1    Persi, N.2    Lador, C.3
  • 91
    • 84934296033 scopus 로고    scopus 로고
    • Improved homing to bone marrow, spleen and lung of adoptively infused NK cells expanded ex vivo with the small molecule nicotinamide using feeder-free conditions
    • M. Berg, T. Peled, R. N. Reger et al., "Improved homing to bone marrow, spleen and lung of adoptively infused NK cells expanded ex vivo with the small molecule nicotinamide using feeder-free conditions", Blood (ASH Annual Meeting Abstracts), vol. 122, p. 897, 2013.
    • (2013) Blood (ASH Annual Meeting Abstracts) , vol.122 , pp. 897
    • Berg, M.1    Peled, T.2    Reger, R.N.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.